home care, hospitals, clinics, and ambulatory surgical centres. Catheters are of various types such as short peripheral intravenous catheters( PIVC), integrated closed PIVCs, and peripherally inserted central catheters( PICC). Central intravenous catheters( CIVC) are used for long-term intravenous access during prevalence of chronic diseases. Therefore, CIVC device market is experiencing a rapid growth in the intravenous catheters segment. There is a huge demand for safety short PIVCs and advanced integrated or closed PIVCs and increased emergency hospital visits. Almost all the specialists in various multispecialty and big healthcare facilities employ PIVCs, CIVCs, and intravenous infusion pumps to administer intravenous medication to the patients.
The global intravenous access devices market is fragmented due to high competition between global and regional players. The leading player in global intravenous access devices are B. Braun Melsungen, BD, C. R. Bard, Smiths Medical, TERUMO CORPORATION, AngioDynamics, APEXMED International, Baxter, Cook Medical, Delta Med, EXELINT International, Fresenius, GaltNeedleTech, Global Medikit, Hospira, ICU Medical, Medtronic, NIPRO Medical, Promed Group, RenovoRx, Retractable Technologies, Teleflex, Vigmed, and Vygon.
Majority of the South Koreans prefer self-administration of drugs using needle-free delivery devices to reduce or avoid medical costs. Many of the patients in South Korea self-administer medicinal drugs using a self-injectable medication. This has led to a huge demand for needlefree drug delivery products, and encourages pharmaceutical companies to invent new selfadministration drugs. Many leading companies around the world are investing heavily in the development of micro-needle drug delivery systems with advanced technology. Various needle free drug delivery systems are jet injectors and transdermal drug delivery systems. It was observed that patients with needle phobia prefer pain-free injections and the alternative is needle-fee drug delivery systems. The needle-free drug delivery systems are used for insulin delivery, vaccination and pain management.
Pulmonary drug delivery systems are Dry powder inhaler( DPI), Metered dose inhaler( MDI) and Nebulisers. These systems deposit pulmonary drugs in the lungs for systemic therapeutic activity. Lungs have a large surface area for absorption, high blood circulation, and high permeability rate; therefore, majority of the chronic obstructive pulmonary disorders are treated through pulmonary route. Pulmonary drugs delivery is accomplished through intranasal administration or oral inhalative administration. Oral inhalative administration includes intratracheal inhalation and intratracheal instillation where drugs are delivered through MDIs, DPIs, and nebulizers. The increasing chronic obstructive pulmonary disorder in South Koreans due to industrial pollution has encouraged this market to continue development.
Intranasal drug delivery systems are medical devices used to administer drugs for local diseases in the nose and paranasal sinus. The continuing technological advancements in intranasal drug